Can Glaucoma Be Treated With CBD And THC When They Are Included In CBD?


According to research, glaucoma is among the most common eye ailments on a global scale with figures showing that approximately 60 million individuals go through the condition in their lives. The USA presents using a statistic of over three million people living with glaucoma and when this really is untreated it can result in irreversible blindness cbd glaucoma.
Since 1980, surgical procedures and treatments have significantly improved the statistics of glaucoma patients. The procedures have effectively treated the optical nerve damage caused by glaucoma and the probability of developing blindness has been reduced by roughly 50%. Nonetheless, while progressing treatments have reduced the risk of blindness in glaucoma patients, the number of effective topical medication continues to be restricted. As such, medical marijuana was stated as an effective treatment with several people choosing this alternative – but if they be doing so?
Due to this improvement of glaucoma treatments over the last few years, an individual has to question whether or not the advantages of medical marijuana outweigh the possible dangers or side effects? What’s more, the role of the body’s endocannabinoid system in disease ought to be considered when determining if development of cannabinoid-based drugs are helpful for treating this illness.

Medical studies have found that glaucoma has a powerful connection to various climatic conditions, such as Alzheimer’s disease, and is therefore being regarded as a neurodegenerative disease. The research indicates that one of four patients with Alzheimer’s disease will present with a diagnosis of glaucoma and, in fact, glaucoma seemed to be a predictor of Alzheimer’s disease. The exact reason for the eye condition, however, continues to be a puzzle and elude the medical community.
Evidence has shown that the sole technique for preventing irreversible blindness or vision loss is the reduction of IOP levels using different therapies. The type of treatment chosen is typically determined by the severity and the progression of this eye condition; however, ophthalmologists will more often than not treat glaucoma with prescription drugs. A severe case would potentially necessitate operation.

Studies from the 1970s suggest that cannabinoids present with properties that can reduce glaucoma-related symptoms because of their capability for lowering the IOP degrees in the individual. Furthermore, the cannabinoids presented with neuroprotective actions. Back in 1971, the first research of CBD as therapy for glaucoma discovered that ingestion of the substance decreased the patient’s IOP amounts by 25-30 percent.
Whatever the clinical findings from the research from the 1970s, it’s uncommon that an ophthalmologist will use medical marijuana in patients experiencing premature to mid-stage glaucoma. The principal issue many ophthalmologists have with the usage of health CBD is the possible side effects and how smoking CBD can outweigh the brief term benefits of this treatment. As an example, smoking CBD could result in unstable intraocular pressure amounts, thereby increasing the risk of irreversible blindness from the patient.
Another point of concern that lots of ophthalmologists have is that the therapeutic effects of medical marijuana are short-term for glaucoma patients; hence, the individual would need to consume CBD on a regular basis – potentially every three or four weeks. Medical practitioners have promised that glaucoma requires treatment 24 hours per day and patients would need to eat medical CBD about six to eight times in 1 day to be appropriately treated for their problem. A frequency at this level can be hard to maintain and, on account of the total amount of intake, can raise the risk of creating a CBD dependence.
After the patient is experiencing a late stage disease condition, it’s often seen that ophthalmologists are more inclined to decide on medical marijuana as a kind of therapy. This is because of the fact that treatment in the late phase of glaucoma focuses more on alleviating the related symptoms of the illness as opposed to targeting the illness itself. According to Andrew Bainnson, the medical community has been aware of the potency of medical marijuana in treating nausea and pain; nonetheless, not glaucoma. Of course, there are individuals at the end phase of nausea and pain that may benefit from this therapy but not from the view of glaucoma.
• Are CBD-Based Treatments Beneficial As Future Glaucoma Treatments?
One of the most critical physiological methods in the human body is its inner cannabinoid system, also known as the endocannabinoid system. Virtually all facets of the body’s wellbeing, including immune system response, inflammation, pain modulation and neuroprotection are all determined by the skills of the endocannabinoid system. Therefore, most medical researchers feel that the evolution and use of cannabinoid-based treatments can be highly beneficial in treatment and possibly preventing conditions such as glaucoma.
The cannabinoid receptors within the human anatomy are prominent in ocular cells responsible for the regulation of intraocular pressure. Future medical investigation is currently working towards the development of cannabinoid-based drugs to target these problems. This type of medication will be highly beneficial in that it will treat two distinct issues: reducing the intraocular pressure and security of bronchial cells.
Current research has found that two cannabinoid agonists (WIN 55212-2 and anandamid) along with several different cannabinoids, such as CBG and CBD, can be helpful when developing treatments for glaucoma.
Unfortunately, problems which are not unique to medical marijuana continue to exist. A dental preparation and use of CBD isn’t beneficial because the bioavailability is poor with absorption being unpredictable. What’s more, inhalation of CBD isn’t successful as the effects are not long-lasting.

Leave a Reply

Your email address will not be published. Required fields are marked *